NYSE : EVH

Evolent Health, Inc. — News

$5.85 USD

-$0.08 (-1.35%)

Volume
1.01M
Average Volume
2.54M
Market Capitalization
$658.01M
P/E Ratio
-1.25
Dividend Yield
0.00%
Price Target
$7.00
Year High
$10.35
Year Low
$2.10
Day High
Day Low
Payout Ratio
-$0.01
Current Ratio
$1.32
Source Headline
Forget Nvidia. These 5 S&P 500 stocks are quietly going all in on AI.

The “Mag Seven” has become the “Bag Seven.” Sharp tech investors are looking elsewhere.

marketwatch.com - 2026-07-20 09:46:00

Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now

Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.

zacks.com - 2026-07-16 16:01:11

Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026

WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open, with a conference call to follow at 8 a.m. ET. Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.

prnewswire.com - 2026-07-08 16:30:00

Should You Buy Evolent Health (EVH) After Golden Cross?

Evolent Health, Inc (EVH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, EVH's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

zacks.com - 2026-07-03 10:56:10

Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?

Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

zacks.com - 2026-06-29 11:56:15

Agentic AI Powers U.S. Healthcare Stocks

Healthcare payrolls keep climbing, and hospital systems, payers, and clinics are now openly treating agentic AI as the cheapest unit of labor on the market.

247wallst.com - 2026-05-17 20:19:15

Evolent Health Q1 Earnings Call Highlights

Evolent Health NYSE: EVH reported first-quarter 2026 results that management said were in line with expectations, while reiterating its full-year outlook and highlighting new contract wins, early progress on major client launches and continued investment in automation.

marketbeat.com - 2026-05-10 05:13:41

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-08 17:31:15

Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-05-07 10:31:28

Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates

Evolent Health (EVH) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $0.06 per share a year ago.

zacks.com - 2026-05-07 09:56:08

Evolent Announces First Quarter 2026 Results

WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2026. Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "I am happy with the strong start to the year.

prnewswire.com - 2026-05-07 07:00:00

Get EVH Insider Trade Alerts

EVH Price Target Summary

Last Month

$7.00

2 analysts

Last Quarter

$6.67

3 analysts

Last Year

$6.50

7 analysts

All Time

$23.68

20 analysts

EVH Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-06-30 Truist Securities Downgrade Buy Hold
2026-06-12 Truist Securities Maintain Buy Buy
2026-05-15 Citigroup Maintain Buy Buy
2026-05-12 Canaccord Genuity Maintain Buy Buy
2026-05-07 Needham Maintain Buy Buy
2026-03-02 Oppenheimer Maintain Outperform Outperform
2026-02-26 Citigroup Maintain Buy Buy
2026-02-26 Truist Securities Maintain Buy Buy
2026-02-26 UBS Maintain Buy Buy
2026-02-25 RBC Capital Maintain Sector Perform Sector Perform
2026-02-25 Keybanc Downgrade Overweight Sector Weight
2026-02-25 Needham Maintain Buy Buy
2026-02-25 BTIG Maintain Buy Buy
2026-02-02 BTIG Maintain Buy Buy
2026-01-09 Citigroup Maintain Buy Buy
2026-01-06 Citizens Maintain Market Outperform Market Outperform